Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is typically considered an age-related disease, but the age at disease onset can vary by decades between patients. Aging and aging-associated diseases can affect the movement system independently of PD, and advanced age has previously been proposed to be associated with a more severe PD phenotype with accelerated progression. In this work, we investigated how interactions between PD progression and aging affect a wide range of outcomes related to PD motor and nonmotor symptoms as well as Health Related Quality of Life (HRQoL) and treatment characteristics. This population-based cohort study is based on 1436 PD patients from southern Sweden followed longitudinally for up to approximately 7.5 years from enrollment (3470 visits covering 2285 patient years, average follow-up time 1.7 years). Higher age at onset was generally associated with faster progression of motor symptoms, with a notable exception of dyskinesia and other levodopa-associated motor fluctuations that had less severe trajectories for patients with higher age at onset. Mixed results were observed for emergence of non-motor symptoms, while higher age at onset was generally associated with worse HRQoL trajectories. Accounting for these identified age-associated differences in disease progression could positively impact patient management and drug development efforts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Despite their shared pathological stages, these diseases display striking differences in the average age of onset [64,65,66,67].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [67]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fitting Linear Mixed-Effects Models Using lme4
Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Goetz, C. G., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stebbins, G. T., Stern, M. B., Tilley, B. C., Dodel, R., Dubois, B., et al. (2007) · Movement Disorders · doi:10.1002/mds.21198 · Cited by 1,404
Variable expression of Parkinson's disease: A base‐line analysis of the DAT ATOP cohort
Jankovic, J., McDermott, M., Carter, J., Gauthier, S., Goetz, C., Golbe, L., Huber, S., Koller, W., Olanow, C., Shoulson, I., et al. (1990) · Neurology · doi:10.1212/wnl.40.10.1529 · Cited by 1,285
Chaudhuri, K. R., Martinez‐Martin, P., Schapira, A. H. V., Stocchi, F., Sethi, K., Odin, P., Brown, R. G., Koller, W., Barone, P., MacPhee, G., et al. (2006) · Movement Disorders · doi:10.1002/mds.20844 · Cited by 1,100
Self-citationChaudhuri, K. R., Martinez‐Martin, P., Brown, R. G., Sethi, K., Stocchi, F., Odin, P., Ondo, W., Abe, K., MacPhee, G., MacMahon, D., et al. (2007) · Movement Disorders · doi:10.1002/mds.21596 · Cited by 1,087
Self-citationRobinson, J. L., Lee, E. B., Xie, S. X., Rennert, L., Suh, E., Bredenberg, C., Caswell, C., Van Deerlin, V. M., Yan, N., Yousef, A., et al. (2018) · Brain · doi:10.1093/brain/awy146 · Cited by 729
Cited by
Cai, X., Chen, Z., He, C., Zhang, P., Nie, K., Qiu, Y., Wang, L., Wang, L., Jing, P., & Zhang, Y. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13984 · Cited by 92
Sun, Q., Zhang, Y., Wang, S., Yang, F., Cai, H., Xing, Y., Zhou, L., Chen, S., & Wang, Y. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113132 · Cited by 31
High risk of developing dementia in Parkinson’s disease: a Swedish registry-based study
Åström, D. O., Simonsen, J., Rakêt, L. L., Sgarbi, S., Hellsten, J., Hagell, P., Norlin, J. M., Kellerborg, K., Martínez‐Martín, P., & Odin, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-21093-8 · Cited by 33
Self-citationNassar, A., Satarker, S., Gurram, P. C., Upadhya, D., Fayaz, S., & Nampoothiri, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03437-1 · Cited by 30
Mammen, J. R., Adams, J., Mangrum, R., Xiao, Y., Barbosa, W. A., Tyo, M. B., Redmond, C., Carter, C., Cifelli, K., Cifelli, R., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00907-2 · Cited by 22
Metadata
- Authors
- Raket, L. L., Oudin Åström, D., Norlin, J. M., Kellerborg, K., Martinez-Martin, P., & Odin, P.
- Affiliations
- Swedish Institute for Health Economics (SE)
- Lund University (SE)
- Corresponding author
- Odin, Per
- Venue
- Scientific Reports
- Published
- 2022-01-11
- Volume
- 12
- Issue
- 1
- Pages
- 526-526
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC8752787
- OpenAlex
- W4205777611
- Cited by
- 72
- References
- 28
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 18 · 2023: 8 · 2022: 7
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Lundbeck A/S
- The Swedish National Government and County Councils
- Skåne University Hospital Foundations and Donations
- Lund University Medical Faculty
- Swedish Parkinson Academy
- Multipark
- Lund University
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, age of onset, disease progression, aging, motor symptoms, non-motor symptoms, health-related quality of life, dyskinesia, antiparkinsonian therapy, symptom trajectories
- MeSH terms
- Aged, Aged, 80 and over, Antiparkinson Agents, Female, Humans, Levodopa, Longitudinal Studies, Male, Middle Aged, Parkinson Disease, Quality of Life, Sweden, Cohort Studies, Age of Onset, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson’s disease. https://app.cochat.ai/papers/10.1038/s41598-021-04356-8
- The paper
- Raket, L. L., Oudin Åström, D., Norlin, J. M., Kellerborg, K., Martinez-Martin, P., & Odin, P. (2022). Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson’s disease. Scientific Reports. https://doi.org/10.1038/s41598-021-04356-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.